CAPITAL GUARDIAN TRUST CO - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL GUARDIAN TRUST CO ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$24,180,000
-45.2%
484,759
-25.1%
0.33%
-44.4%
Q1 2019$44,125,000
+51.8%
647,360
+2.7%
0.59%
+26.6%
Q4 2018$29,067,000
-41.6%
630,379
-2.4%
0.46%
-31.1%
Q3 2018$49,813,000
-8.5%
645,912
-0.0%
0.67%
-13.3%
Q2 2018$54,413,000
+0.6%
646,009
-2.3%
0.78%
+1.7%
Q1 2018$54,078,000
+42.7%
661,262
-0.3%
0.76%
+41.9%
Q4 2017$37,909,000
-22.2%
663,089
-9.1%
0.54%
-36.6%
Q3 2017$48,708,000
+21.2%
729,714
-6.5%
0.85%
+14.9%
Q2 2017$40,172,000
-26.4%
780,800
-16.5%
0.74%
+80.6%
Q1 2017$54,597,000
+60.3%
934,879
+14.5%
0.41%
+52.8%
Q4 2016$34,060,000
+0.7%
816,200
+27.5%
0.27%
+4.7%
Q3 2016$33,815,000
+20.8%
640,200
-4.2%
0.26%
+18.6%
Q2 2016$27,990,000
+62.6%
668,100
+57.6%
0.22%
+62.9%
Q1 2016$17,211,000
-39.0%
423,922
-2.4%
0.13%
-39.7%
Q4 2015$28,197,000
-3.7%
434,341
+4.7%
0.22%
-7.6%
Q3 2015$29,280,000
-63.7%
414,790
-42.8%
0.24%
-59.3%
Q2 2015$80,663,000
+12.7%
725,780
-4.4%
0.58%
+9.6%
Q1 2015$71,598,000
-5.3%
759,256
+12.5%
0.53%
+1.3%
Q4 2014$75,615,000674,8900.52%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders